BACKGROUND: Although it is recommended that smokers undergoing surgery for lung cancer quit smoking to reduce post-operative complications, few studies have examined patterns of smoking in the peri-operative period. The goals of this study were to determine: (1) patterns of smoking during post-operative recovery, (2) types of cessation strategies used to quit smoking, and (3) factors related to smoking after lung cancer surgery. METHODS: Data were collected from 94 patients through chart review, tobacco, health status, and symptom questionnaires at 1, 2, and 4 months after surgery. Smoking status was assessed through self-report and urinary cotinine measurement. RESULTS: Eighty-four patients (89%) were ever-smokers and 35 (37%) reported smoking at diagnosis. Thirty-nine (46%) ever-smokers remained abstinent, 13 (16%) continued smoking at all time-points, and 32 (38%) relapsed. Ten (46%) of those who relapsed were former-smokers and had not smoked for at least 1 year. Sixteen (46%) of those who were smoking at diagnosis received cessation assistance with pharmacotherapy being the most common strategy. Factors associated with smoking during recovery were younger age and quitting smoking < or =6 months before the diagnosis of lung cancer. Factors that were marginally significant were lower educational level, male gender, lower number of comorbidities, and the presence of pain. CONCLUSION: Only half of those who were smoking received assistance to quit prior to surgery. Some patients were unable to quit and relapse rates post-surgery were high even among those who quit more than 1 year prior. Innovative programs incorporating symptom management and relapse prevention may enhance smoking abstinence during post-operative care.
BACKGROUND: Although it is recommended that smokers undergoing surgery for lung cancer quit smoking to reduce post-operative complications, few studies have examined patterns of smoking in the peri-operative period. The goals of this study were to determine: (1) patterns of smoking during post-operative recovery, (2) types of cessation strategies used to quit smoking, and (3) factors related to smoking after lung cancer surgery. METHODS: Data were collected from 94 patients through chart review, tobacco, health status, and symptom questionnaires at 1, 2, and 4 months after surgery. Smoking status was assessed through self-report and urinary cotinine measurement. RESULTS: Eighty-four patients (89%) were ever-smokers and 35 (37%) reported smoking at diagnosis. Thirty-nine (46%) ever-smokers remained abstinent, 13 (16%) continued smoking at all time-points, and 32 (38%) relapsed. Ten (46%) of those who relapsed were former-smokers and had not smoked for at least 1 year. Sixteen (46%) of those who were smoking at diagnosis received cessation assistance with pharmacotherapy being the most common strategy. Factors associated with smoking during recovery were younger age and quitting smoking < or =6 months before the diagnosis of lung cancer. Factors that were marginally significant were lower educational level, male gender, lower number of comorbidities, and the presence of pain. CONCLUSION: Only half of those who were smoking received assistance to quit prior to surgery. Some patients were unable to quit and relapse rates post-surgery were high even among those who quit more than 1 year prior. Innovative programs incorporating symptom management and relapse prevention may enhance smoking abstinence during post-operative care.
Authors: David W Wetter; Ludmila Cofta-Gunn; Jennifer E Irvin; Rachel T Fouladi; Kelli Wright; Patricia Daza; Carlos Mazas; Paul M Cinciripini; Ellen R Gritz Journal: Prev Med Date: 2005-04 Impact factor: 4.018
Authors: Steven S Fu; Melissa R Partin; Annamay Snyder; Lawrence C An; David B Nelson; Barbara Clothier; Sean Nugent; Mark L Willenbring; Anne M Joseph Journal: Am J Manag Care Date: 2006-04 Impact factor: 2.229
Authors: Wei Zhou; Rebecca S Heist; Geoffrey Liu; Kofi Asomaning; David P Miller; Donna S Neuberg; John C Wain; Thomas J Lynch; David C Christiani Journal: Clin Cancer Res Date: 2006-12-01 Impact factor: 12.531
Authors: Peyman Sardari Nia; Joost Weyler; Cecile Colpaert; Peter Vermeulen; Eric Van Marck; Paul Van Schil Journal: Lung Cancer Date: 2005-03 Impact factor: 5.705
Authors: Linda Sarna; Jean K Brown; Mary E Cooley; Roma D Williams; Cynthia Chernecky; Geraldine Padilla; Leda Layo Danao Journal: Oncol Nurs Forum Date: 2005-01-19 Impact factor: 2.172
Authors: Elyse R Park; Sandra J Japuntich; Nancy A Rigotti; Lara Traeger; Yulei He; Robert B Wallace; Jennifer L Malin; Jennifer P Zallen; Nancy L Keating Journal: Cancer Date: 2012-01-23 Impact factor: 6.860
Authors: Erika Litvin Bloom; Jason A Oliver; Steven K Sutton; Thomas H Brandon; Paul B Jacobsen; Vani Nath Simmons Journal: Psychooncology Date: 2014-09-25 Impact factor: 3.894
Authors: Henrietta L Logan; Roger B Fillingim; Linda M Bartoshuk; Pamela Sandow; Scott L Tomar; John W Werning; William M Mendenhall Journal: J Pain Date: 2009-12-16 Impact factor: 5.820
Authors: Jessica L Burris; Jamie L Studts; Antonio P DeRosa; Jamie S Ostroff Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-08-17 Impact factor: 4.254
Authors: Diana B Díaz; Thomas H Brandon; Steven K Sutton; Lauren R Meltzer; Hannah J Hoehn; Cathy D Meade; Paul B Jacobsen; Judith C McCaffrey; Eric B Haura; Hui-Yi Lin; Vani N Simmons Journal: Contemp Clin Trials Date: 2016-07-25 Impact factor: 2.226